Last reviewed · How we verify
SN1011
At a glance
| Generic name | SN1011 |
|---|---|
| Sponsor | SinoMab BioScience Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SN1011 CI brief — competitive landscape report
- SN1011 updates RSS · CI watch RSS
- SinoMab BioScience Ltd portfolio CI